Delivery Order SPE2DB24D2010-SPE2DB25FAASW
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,971.47 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. The contract, awarded on August 12, 2025, with completion targeted for August 13, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, executed this order through its Corporate Office division. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.84 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed price delivery order, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a routine pharmaceutical procurement under the company's broader relationship with DLA. The contract was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,047.69 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone treatment. The contract is a firm fixed price delivery order with an ultimate completion date of August 28, 2025, issued on August 27, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award carries no set-aside designation and was competitively awarded to the prime...
- The Defense Logistics Agency awarded a delivery order valued at $2,354.52 to AmerisourceBergen Drug Corp for Norditropin Flexpro 10 mg/1.5 mL, a human growth hormone medication. The award, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a firm fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same jurisdiction. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,164.10 to AmerisourceBergen Drug Corp for Norditropin FlexPro 5 mg/1.5 mL, a human growth hormone medication. This firm fixed-price, non-set-aside contract was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a relatively small transaction within the company's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed-price delivery order, valued at $6,984.60, is scheduled for completion by September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively granted with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $3,492.30 delivery order to AmerisourceBergen Drug Corp for Norditropin Flexpro 15 mg/1.5 mL, a human growth hormone medication. This contract is classified as a firm fixed price delivery order with an ultimate completion date of August 22, 2025, and was awarded on August 21, 2025. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,499.03 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 ml, a human growth hormone medication. The contract, issued on July 21, 2025, with completion targeted for July 22, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,688.10 to AmerisourceBergen Drug Corp for Norditropin Flexpro 10 mg/1.5 ml pharmaceutical supplies. This firm fixed-price, non-set-aside contract was awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. Norditropin is a human growth hormone therapeutic used to treat growth disorders and other endocrine conditions, making...
- The Defense Logistics Agency awarded a delivery order valued at $1,164.10 to AmerisourceBergen Drug Corp for Norditropin FlexPro 5 mg/1.5 mL, a human growth hormone medication. This firm fixed price contract, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, was competitively awarded with no set-aside designation. The vendor, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. This delivery order is issued under...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAASWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,143.07 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Norditropin is a human growth hormone therapeutic used in medical treatment, and this delivery represents a discrete supply order fulfilling immediate federal healthcare requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare systems globally, enabling the company to deliver a broad range of pharmaceutical products, specialty medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen Drug Corp's consistent performance across competitive federal procurements demonstrates its capability as a critical pharmaceutical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/7/25 |